Shares of Endo Pharmaceuticals are currently trading below their 50-day moving average (MA) of $35.38 and should find support at their 200-day MA of $28.89. Look for the MA to provide resistance for a short-term rebound in the shares.
Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical company with products that provide pain management. The Company researches, develops, produces, and markets both branded and generic pharmaceuticals. Endo's products include Percocet, Percodan, and Lidoderm.